Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Csl Behring LLC currently has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to a matching number of distinct examiners, meaning each pending matter is handled by a different individual. The prosecution activity is spread across multiple distinct art units, indicating that every pending action is being reviewed by a different specialized group within the patent office.
KO, JASON Y is the busiest examiner for this portfolio, with 1 pending office action currently under review. Since there are 3 distinct examiners for the matters, the workload is perfectly distributed. The fact that all matters are situated in distinct art units suggests that the company is interacting with multiple specialized departments, ensuring that each application is evaluated independently.
Practitioners should note that the matters are spread across multiple examiners and art units, which requires a highly individualized approach for each application. The presence of multiple examiners provides insulation against the specific tendencies of any one individual. This portfolio's 3 pending office actions represent the entirety of its current active prosecution in this technology area.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KO, JASON Y | 1 | 75.6% | +16.7% |
| BEANE, RANDALL L | 1 | 32.8% | +36.8% |
| ZHU, JIANJIAN | 1 | 58.8% | +82.4% |
| MCLEOD, AFRICA MHAIRIE | 1 | 51.9% | +67.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18847807 | APPARATUS AND METHOD FOR CLEANING FILTER PLATES | KO, JASON Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17353440 | NANOCAPSULES FOR THE DELIVERY OF CELL MODULATING AGENTS | MCLEOD, AFRICA MHAIRIE | 42d overdue |
| 18513964 | Methods for Reducing Risk of Onset of Acute Graft Versus Host Disease After Hematopoeitic Cell Transplantation | BEANE, RANDALL L | 70d |
| 18847807 | APPARATUS AND METHOD FOR CLEANING FILTER PLATES | KO, JASON Y | — |
| 18078977 | DONOR T-CELLS WITH KILL SWITCH | ZHU, JIANJIAN | — |
| Art Unit | Apps |
|---|---|
| 1711 | 1 |
| 1654 | 1 |
| 1631 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18847807 | APPARATUS AND METHOD FOR CLEANING FILTER PLATES | KO, JASON Y | 1711 | §102§103 | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18513964 | Methods for Reducing Risk of Onset of Acute Graft Versus Host Disease After Hematopoeitic Cell Transplantation | BEANE, RANDALL L | 1654 | §103 | Final Rejection | 70d | Pending | Nov 20, 2023 |
| 18078977 | DONOR T-CELLS WITH KILL SWITCH | ZHU, JIANJIAN | 1631 | §103§112DPOther | Non-Final OA | — | Pending | Dec 11, 2022 |
| 17353440 | NANOCAPSULES FOR THE DELIVERY OF CELL MODULATING AGENTS | MCLEOD, AFRICA MHAIRIE | 1635 | §103 | Non-Final OA | 42d overdue | Pending | Jun 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial